CRNX logo
CRNX NASDAQ US

Crinetics Pharmaceuticals, Inc. - Common Stock

Healthcare · Pharmaceuticals Sito web · IPO Lug 2018
$37,23
▲ +$0,66 (+1,80%)
Vol. 1.2M
2
Punteggio di Qualità
fail
Cap. mercato
$4.4B
ROE
-35,1%
Margine
-22312,8%
D/E
0,00
Beta
0,19
52W
$24–$55

Consenso Wall Street

22 analisti · Apr 2026
7
Acquisto forte
13
Compra
2
Mantieni
0
Vendi
0
Vendita forte
90,9%
Rating Compra

Grafico dei Prezzi

Titoli simili

BLTE
Belite Bio Inc
$5.6B
TERN
Terns Pharmaceuticals Inc
$4.3B
CORT
Corcept Therapeutics Inc
P/E 34,5
$3.7B
LGND
Ligand Pharmaceuticals Inc
P/E 76,6
$3.7B
AMRX
Amneal Pharmaceuticals Inc
P/E 671,4
$4.0B
INDV
Indivior Pharmaceuticals, Inc
P/E 35,8
$4.5B
GPCR
Structure Therapeutics Inc
$4.2B
EWTX
Edgewise Therapeutics Inc
$2.6B
LQDA
Liquidia Corp
$3.0B
TARS
Tarsus Pharmaceuticals Inc
$3.5B

Utili

Tasso di battuta: 25,0%
Prossimo report Mag 06, 2026
Stima EPS: $-1,25
Trimestre EPS Stimato EPS Effettivo Sorpresa
Mar 2026 $-1,25 — —
Dic 2025 $-1,39 $-1,29 +$0,10
Set 2025 $-1,28 $-1,38 $-0,10
Giu 2025 $-1,12 $-1,23 $-0,11

Ricavi e utili trimestrali

Trimestre 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Ricavi — $361K $1.0M $143K $6.2M
Utile netto -$80.6M -$96.8M -$115.6M -$130.1M -$122.8M

Trend fondamentali

Metrica 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -32.3% -32.3% -32.3% -32.3% -35.1% -35.1%
P/E (TTM) — — — — — —
Net Margin -11216.0% -15259.4% -15259.4% -15259.4% -22312.8% -22312.8%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 17.80 17.80 17.80 17.80 15.12 15.12

Rapporti chiave

ROA (TTM)
-32,0%
P/S (TTM)
2877,66
P/B
3,6
EPS (TTM)
$-4,53
CF/Share
$-3,61
Crescita ricavi 3A
-1,3%
52W High
$54,78
52W Low
$24,10
$24,10 Intervallo 52 settimane $54,78

Salute finanziaria

Flusso di cassa libero
-$93.4M
Debito netto
-$53.0M
Liquidità
$101.5M
Debito totale
$48.5M
Aggiornato al Dic 31, 2025

Як CRNX виглядає на тлі конкурентів у Pharmaceuticals?

Група порівняння: Mid-cap Pharmaceuticals ($2B+) · 25 компаній

CRNX AMRX AVDL AXSM AZN

Оцінка CRNX vs аналоги Pharmaceuticals

P/E
—
▼ 0% sotto peer (30,7)
vs Peer
vs Settore
Valore equo
P/S
2877,7
▲ 42722% sopra peer (6,7)
vs Peer
vs Settore
Sopravvalutato
P/B
3,6
▼ 31% sotto peer (5,2)
vs Peer
vs Settore
Più costoso
Дивідендна дохідність
—
▼ 0% sotto peer (3,1%)
vs Peer
vs Settore
Rendimento basso

Прибутковість CRNX vs аналоги Pharmaceuticals

ROE
-35,1%
▼ 35% sotto peer (-26,1%)
vs Peer
vs Settore
Debole
Net margin
-22312,8%
▼ 1538716% sotto peer (-1,5%)
vs Peer
vs Settore
Debole
Валова маржа
—
▼ 0% sotto peer (88,9%)
vs Peer
vs Settore
Top livello
ROA
-32,0%
▼ 239% sotto peer (-9,5%)
vs Peer
vs Settore
Debole

Фінансове здоровʼя CRNX vs аналоги Pharmaceuticals

D/E ratio
0,0
▼ 100% sotto peer (27,4)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
15,1
▲ 335% sopra peer (3,5)
vs Peer
vs Settore
Liquidità forte
Beta
0,2
▼ 68% sotto peer (0,6)
vs Peer
vs Settore
Più volatile

Радар фундаменталів CRNX

CRNX Mediana peer Industria

CRNX прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

CRNX vs аналоги: ключові метрики

Attività insider

Neutral
Acquisti
0
Vendite
0
BETZ STEPHEN F
Officer · Mar 16
10612 shs
STRUTHERS RICHARD SCOTT
Chief Executive Officer · Mar 16
21981 shs
KNIGHT JEFF E
Chief Operating Officer · Mar 16
9911 shs
VIVALDI COELHO ROGERIO
Director · Mar 12
5000 shs
SCHILKE TOBIN
Chief Financial Officer · Mar 03
6713 shs
OKEY STEPHANIE S
Director · Mar 03
3000 shs
SCHILKE TOBIN
Chief Financial Officer · Feb 23
32000 shs
STRUTHERS RICHARD SCOTT
Chief Executive Officer · Feb 23
62000 shs
KNIGHT JEFF E
Chief Operating Officer · Feb 23
34000 shs
BETZ STEPHEN F
Officer · Feb 23
30000 shs
Ultimo 90 giorni

Principali azionisti

Top 5: 44,3%
FMR, LLC
13,65%
$481.3M
Vanguard Group Inc
8,72%
$307.6M
Wellington Management Group…
7,68%
$270.6M
Blackrock Inc.
7,63%
$269.0M
Farallon Capital Management…
6,62%
$233.4M
Aggiornato al Dic 31, 2025

Ultime notizie

Nessuna notizia correlata ancora